The global dental market demonstrated increased stability in the second quarter of the current year, although demand for capital equipment remains under pressure. Four largest international manufacturers of dental materials and equipment presented mixed, but overall stable performance indicators.
The last decade tested the reputation of dentistry as a reliable and stable sector of the economy. The industry, traditionally considered resistant to financial market fluctuations, proved sensitive to growing pressure from macroeconomic factors: inflation, rising interest rates, and changes in consumer demand. Patient demand remained stable in many regions, including North America, while the capital equipment market remained weak, whereas sales of implants, consumables, and aligners showed growth.
Straumann Group’s revenue in the second quarter amounted to 707 million Swiss francs (766 million euros), which is 5.9% higher than the previous year’s figures with organic growth of 8.5%. The company recorded sales growth in all geographical regions. In the EMEA region, revenue reached 285 million francs (+5.4% year-over-year); Germany, Poland, and Hungary showed the most stable growth. Sales of implantology products served as the main growth driver.
In North America, sales increased by 4.0% year-over-year (8.4% in organic terms) to 178 million francs, recovering after a decline of 5.6% in the previous quarter thanks to cooperation with dental support organizations. Particularly significant was the resumption of growth in the Asia-Pacific region: revenue amounted to 178 million francs (+4.9% year-over-year). Excluding China, organic growth in the region reached 25% — modest growth in mainland China is explained by delays in the implementation of the state procurement program in terms of volume. Growth in Japan, India, and Southeast Asia was characterized as very intensive. In Latin America, sales increased by 17% to 67 million francs, with the main contribution from Brazil, Mexico, Argentina, and Colombia.
Align Technology reported record second quarter revenue of 1.06 billion US dollars (929 million euros), an increase of 4.3% year-over-year. Revenue from the aligner business increased by 8.2% to 871 million dollars, however, profit was partially offset by a decline in visualization systems and CAD/CAM services sales by 10.8% to 185 million dollars.
Revenue growth was provided by record volumes of aligner shipments: 691,785 cases, which is 7.4% higher than the previous year. The number of specialists trained for Invisalign treatment increased to 89,175 from 86,250, while the average number of cases per participant increased from 7.5 to 7.8. Growth in volumes was observed among both orthodontists and general practitioners, as well as across all patient age groups. International markets showed outpacing growth, with double-digit growth rates in the Asia-Pacific region, EMEA, and Latin America.
Align’s decision to reduce prices on intraoral scanners and diversify purchase options was accompanied by double-digit increases in the number of installed devices and 16% year-over-year growth in the number of scans performed (12.4 million in the second quarter). The company’s management defined this as a strategy to expand diagnostic accessibility and strengthen Align Digital Platform’s position.
Dentsply Sirona’s revenue in the second quarter amounted to 898 million dollars, a decline of 4.1% year-over-year (6.3% on a constant currency basis). Net income improved to 37 million dollars from losses of 45 million dollars a year ago. All company divisions showed a decline in sales. Global sales of connected technology solutions fell by 1.5% to 239 million dollars; core dental solutions — by 2.7% to 376 million dollars; orthodontic and implantology solutions — by 13.2% to 197 million dollars.
The company is in the middle of a 24-month action plan aimed at returning to growth. The program provides for significant commercial restructuring, particularly in the American market, as well as investments in global clinical education and sales support infrastructure. Management notes stabilization of the global dental market with a forecast of 3% growth for 2026, but emphasizes that the transition from negative to positive growth will require time. A more favorable result is expected in the third quarter and positive annual growth in the US by year-end.
Envista Holdings Corp.’s sales in the second quarter amounted to 731 million dollars, an increase of 7.1% year-over-year (base growth 5.0%). The Specialty Products and Technologies division received 471 million dollars (+5.8% year-over-year, base growth 3
Canada’s largest dental practice support organization (DSO) Dentalcorp has expanded its portfolio by 21 clinics by acquiring Northstar Dental Partners
A new national income report shows an increase in taxable income of self-employed dentists across all countries of the United
OTEXE.COM uses cookies to personalize the services and improve the usability of the site. If you do not want to use cookies, please disable them in your browser settings.
